Latest News

This company has a long runway to grow and trades at a discounted price.
Via The Motley Fool · August 26, 2025

Shareholder value is going up as the share count is going down.
Via The Motley Fool · August 26, 2025

While clean energy has been battered by recent legislation, NextEra Energy stock has been on the rise.
Via The Motley Fool · August 26, 2025

The biggest stocks in the market command premium prices, but are they worth it?
Via The Motley Fool · August 26, 2025

The list of the world's largest utilities is topped by a U.S. company that has a powerful mix of new and old driving its growth and dividend higher.
Via The Motley Fool · August 26, 2025
Via Talk Markets · August 26, 2025

Powell’s Jackson Hole speech signals a bold policy shift as the Fed prioritizes labor market stability over inflation, paving the way for a September rate cut.
Via Talk Markets · August 26, 2025

Palantir was just awarded a $10 billion megadeal with the U.S. Army.
Via The Motley Fool · August 26, 2025

MINISO's stock surged as its global superstore strategy and high-margin IP products proved to be a powerful, profitable formula for international growth.
Via MarketBeat · August 26, 2025
As Trump moves to block new permits for wind and solar projects, renewables—which were enjoying a strong year—will likely pull back. But opportunities remain.
Via MarketBeat · August 26, 2025
Via Benzinga · August 26, 2025
Curious about Booking Holdings' future? Our experts break down the company's strengths and potential risks, revealing whether it's a buy or a pass for investors.
Via The Motley Fool · August 26, 2025
Via Benzinga · August 26, 2025

Three standout firms reporting earnings in the last week of August have analyst support and investor attention—but how will they perform?
Via MarketBeat · August 26, 2025
Here's the MongoDB Q2 earnings call. transcript.
Via Benzinga · August 26, 2025
Via Benzinga · August 26, 2025

Some professionals tracking the company feel its potential isn't immense just now.
Via The Motley Fool · August 26, 2025

A competitor reported a successful late-stage clinical trial of a drug that could be very competitive with Wegovy.
Via The Motley Fool · August 26, 2025
Here's the transcript of the nCino Q2 earnings call.
Via Benzinga · August 26, 2025

The company's latest reported quarter featured a double-digit percentage revenue increase, and a much narrower net loss.
Via The Motley Fool · August 26, 2025
More consumers expect a challenging job market.
Via Talk Markets · August 26, 2025